Microinjection of herpes simplex virus (HSV)-infected cell mRNA into Xenopus laevis oocytes resulted in the production of a new exonuclease activity. This enzyme strongly resembled the HSV alkaline exonuclease in many biochemical properties, and hybrid-arrested translation studies showed that it was virus coded, mapping at 0.080 to 0.185 genome map units. Exonuclease mRNA had a size and genome location equivalent to the mRNA encoding V185 in reticulocyte lysates, suggesting that VI85 is the exonuclease. The enzyme synthesized in oocytes was found to act as an exonuclease in vivo. Two plasmids containing HSV DNA fragments directed the synthesis of exonuclease when microinjected into oocyte nuclei, and this finding enabled the coding and control sequences for this gene to be localized to 0.155 to 0.185 genome map units.Infection of cells with herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2) results in the production of an alkaline exonuclease (9,10,21,28). At least one essential component of this enzyme is virus coded, since the activity induced by the HSV-2 mutant ts13 is thermolabile (7, 23). The role of the exonuclease in the virus replication cycle is unclear at present.It has been shown previously that mRNAdirected synthesis of HSV-specified thymidine (pynmidine deoxyribonucleoside) kinase (TK) can be detected in the reticulocyte lysate cellfree system, provided appropriate assay conditions are used (5,25,29). These methods have facilitated studies on the size and genome map location of TK mRNA (5, 27), and have enabled the transcriptional control of the TK gene to be investigated (26). We report here that microinjection of HSV-infected cell mRNA into Xenopus laevis oocytes results in the production of active exonuclease, and therefore that similar studies are possible with this enzyme. We further show that synthesis of HSV exonuclease occurs after microinjection of suitable plasmid DNAs into oocyte nuclei.
MATERIALS AND METHODSPlasmid DNAs. The plasmid DNAs used in these studies were as follows: (i) pGX41, which consists of the HSV-1 EcoRI D fragment cloned into the EcoRI site of pACYC184 (prepared by B. Matz); (ii) pGX24, which consists of the HSV-1 BamHI A fragment cloned into the BamHI site of pAT153 (prepared by V. Preston); and (iii) pGZ65, which consists of the HSV-2 BamHI F fragment cloned into the BamHI site of pAT153 (prepared by A. Davison). For microinjection into X. laevis oocytes, plasmid DNAs were purified by sucrose density gradient centrifugation.RNA preparations. Total cytoplasmic RNA was extracted from BHK cells at 5 h after infection with 20 PFU of HSV-1 or HSV-2 per cell at 31°C, as described previously (24). Polyadenylated RNA [poly(A)+ RNA] was selected from total cytoplasmic RNA by oligodeoxythymidylic acid-cellulose chromatography.For size fractionation, RNA was denatured by incubation in 50%o formamide-50 mM PIPES [piperazine-N-N'-bis(2-ethanesulfonic acid)] buffer (pH 7.4) at 60°C for 10 min, diluted twofold, and loaded onto a 13ml 15 to 40% sucrose density gradient prepared in ...